Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating DT-101 as a potential treatment for adults with Major Depressive Disorder MDD. This study compares the effects of DT-101 to a placebo to understand how it may impact depression symptoms. The study also aims to assess the safety and tolerability of DT-101 in this population. Participants will be randomly assigned to receive one of two versions of DT-101 or a placebo. The study involves physical and neurological exams, blood and urine sample collection, and clinical assessments. Blood samples will also be analyzed to study how DT-101 is absorbed and processed by the body and to explore genetic factors that may influence response to the drug. Throughout the study, participants will attend clinic visits approximately every two weeks for health checks and to complete questionnaires about their depression. Researchers will monitor changes in depression severity using the Montgomery sberg Depression Rating Scale MADRS and other clinical measures over 42 days. Safety and ongoing suitability for participation will be regularly evaluated, with the total study duration extending up to about six weeks.